Progressive Supranuclear Palsy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Blink Reflex Recovery Cycle May Distinguish PSP From CBD Blink Reflex Recovery Cycle May Distinguish PSP From CBD
For indeterminate diagnoses, the R2 blink reflex recovery cycle can help distinguish between progressive supranuclear palsy and corticobasal degeneration, a study shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - October 12, 2017 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Palliative care and its emerging role in Multiple System Atrophy and Progressive Supranuclear Palsy
This review aims to discuss the trajectory of disease in MSA and PSP, explore significant symptoms and summarize some evidence which exists for palliative care need and quality of life in these conditions. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 28, 2017 Category: Consumer Health News Source Type: news
Progressive Supranuclear Palsy
(Symptoms, Stages, Treatment, and Life Expectancy) (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 3, 2017 Category: Journals (General) Source Type: news
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds
Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has entered into two separate agreements to license BMS-986168, an anti-eTau compound in development for Progressive Supranuclear Palsy (PSP), to Biogen (NASDAQ:BIIB), and BMS-986089, an anti-myostatin adnectin in development for Duchenne Muscular Dystrophy (DMD), to Roche. (Source: World Pharma News)
Source: World Pharma News - April 13, 2017 Category: Pharmaceuticals Tags: Featured Bristol-Myers Squibb Business and Industry Source Type: news
A protein called PERK may be a target for treating progressive supranuclear palsy
(DZNE - German Center for Neurodegenerative Diseases) The brain disease 'progressive supranuclear palsy' (PSP) is currently incurable and its symptoms can only be eased to a very limited degree. PSP impairs eye movements, locomotion, balance control, and speech. Scientists at the DZNE and the Technical University of Munich (TUM) have now discovered a molecular mechanism that may help in the search for effective treatments. A team of researchers led by G ü nter H ö glinger reports on this in the journal 'EMBO Molecular Medicine'. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2017 Category: Global & Universal Source Type: news
AbbVie begins Phase II trial of ABBV-8E12 to treat Alzheimer's and PSP
US-based biopharmaceutical firm AbbVie has begun Phase II clinical trial programmes of its ABBV-8E12 antibody to treat patients with early Alzheimer's disease and progressive supranuclear palsy (PSP). (Source: Drug Development Technology)
Source: Drug Development Technology - January 27, 2017 Category: Pharmaceuticals Source Type: news
Understanding falls in progressive supranuclear palsy - Bluett B, Litvan I, Cheng S, Juncos J, Riley DE, Standaert DG, Reich SG, Hall DA, Kluger B, Shprecher D, Marras C, Jankovic J.
INTRODUCTION: Progressive supranuclear palsy (PSP) is characterized by frequent falls which worsen with disease progression, causing substantial morbidity and mortality. Few studies have investigated which factors contribute to falls in PSP, and all have i... (Source: SafetyLit)
Source: SafetyLit - December 30, 2016 Category: Global & Universal Tags: Age: Elder Adults Source Type: news
Completed suicide in a case of clinically diagnosed progressive supranuclear palsy - Wiener J, Moran MT, Haut MW.
We present the clinical history and the cognitive and behavioral presentations of a male patient with suspected progressive supranuclear palsy (PSP) who fatally shot himself in the head. We believe his act of suicide was the consequence of impulsivity, rat... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 31, 2015 Category: Global & Universal Tags: Suicide and Self-Harm Source Type: news
AbbVie and C2N’s humanised anti-tau antibody obtains FDA orphan drug status for PSP
AbbVie and C2N Diagnostics have received orphan drug designation from the US Food and Drug Administration (FDA) for their investigational recombinant humanised anti-tau antibody, C2N-8E12 (ABBV-8E12), to treat progressive supranuclear palsy (PSP). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - July 19, 2015 Category: Pharmaceuticals Source Type: news
Progressive Supranuclear Palsy Therapeutic Pipeline Assessment Review...
RnRMarketResearch.com adds “Progressive Supranuclear Palsy - Pipeline Review, H1 2015” to its store. The report provides an overview of the Progressive Supranuclear Palsy’s therapeutic pipeline.(PRWeb June 23, 2015)Read the full story at http://www.prweb.com/releases/progressive-supranuclear/palsy-pipeline-review/prweb12802853.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - June 23, 2015 Category: Pharmaceuticals Source Type: news
Similar but different: New discovery for degenerative diseases
Researchers have established how two diseases that present in similar ways are in fact quite different. Progressive Supranuclear palsy and Parkinson's Disease have overlapping symptoms but remain difficult to distinguish. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 10, 2014 Category: Science Source Type: news
Cognitive dysfunction associated with falls in progressive supranuclear palsy - Kim SL, Lee MJ, Lee MS.
BACKGROUND: Attentional and executive dysfunctions are associated with falls in community-dwelling elderly individuals and patients with PD. Frontal cognitive dysfunction and falls are frequent symptoms of PSP. We studied to identify the cognitive domains ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 8, 2014 Category: Global & Universal Tags: Falls Source Type: news
Cortice begins patient enrolment in Phase I trial of TPI 287 to treat rare tauopathy diseases
US-based Cortice Biosciences has initiated enrolling patients in a Phase I trial of its lead drug candidate, TPI 287, for treatment of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). (Source: Drug Development Technology)
Source: Drug Development Technology - July 8, 2014 Category: Pharmaceuticals Source Type: news
Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer - Ling H, Kara E, Revesz T, Lees AJ, Plant GT, Martino D, Houlden H, Hardy J, Holton JL.
We report the case of a 75-year-old ex-professional boxer who developed diplopia and eye movement abnormalities in his 60's followed by memory impairment, low mood and recurrent falls. Examination shortly before death revealed hypomimia, dysarthria, vertic... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - February 28, 2014 Category: Global & Universal Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
I have PSP. The neurologist said: 'I can't do anything for you'
Keith Sw.ie has a rare and fatal neurological disease. Now, he is trying to raise the profile of progressive supranuclear palsy, a condition even most GPs would fail to recogniseIt was his eyes clamping shut that first prompted Keith Sw.ie to talk to his doctor. The supermarket manager was 38 years old and never imagined that the bouts of blindness were the first symptoms of a rare condition that will eventually kill him.Sw.ie has a disease that hardly anyone has heard of: progressive supranuclear palsy (PSP). Often confused with other neuro-degenerative conditions such as Parkinson's disease, PSP is more commonly found in...
Source: Guardian Unlimited Science - December 8, 2013 Category: Science Authors: Katie Allen Tags: The Guardian Health & wellbeing Neuroscience Features Life and style Source Type: news
Botulinum Toxin Benefits Many PSP Patients With DystoniaBotulinum Toxin Benefits Many PSP Patients With Dystonia
For patients with progressive supranuclear palsy, botulinum toxin A injections relieve disabling blepharospasm and neck and hand dystonia. The greatest benefit is in treating blepharospasm. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 18, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Alzheimer's Mouse Model Shows Transmission Of Tangles, Provides More Authentic Model Of Tau Pathology
Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments. Tau tangles are also found in progressive supranuclear palsy, cortical basal degeneration and other related tauopathies, including chronic traumatic encephalopathy due to repetitive traumatic brain injuries sustained in sports or on the battle field... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 17, 2013 Category: Consumer Health News Tags: Alzheimer's / Dementia Source Type: news